Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Bj Rimel"'
Autor:
Dandi Huang, Reed O'Connor, Katherine Moran, Justin Kim, Anthony Do, Margaret Liang, BJ Rimel, Kenneth Kim
Publikováno v:
Gynecologic Oncology Reports, Vol 48, Iss , Pp S14- (2023)
Objectives: To evaluate the patterns of inpatient (IP) vs outpatient (OP) initiation of palliative care (PC) with a focus on primary language and factors associated with successful IP to OP PC transition in in gynecological cancer patients. Methods:
Externí odkaz:
https://doaj.org/article/037d72500afe4cb5b1418353f2e326d5
50 Therapeutic opportunities in the master transcription factor circuitries of clear cell carcinomas
Autor:
Nolan J. Kinne, Soledad Ochoa, Marla Scott, Forough Abbasi, Pak Hin Yu, Marcela Haro, BJ Rimel, Kate Lawrenson
Publikováno v:
Gynecologic Oncology Reports, Vol 48, Iss , Pp S25-S26 (2023)
Objectives: Transcription factors are emerging as targets for novel therapeutics for the treatment of malignancies. We sought to evaluate functions of PAX8 and HNF1B in both clear cell ovarian cancer (CCOC) and clear cell renal cell carcinoma (ccRCC)
Externí odkaz:
https://doaj.org/article/e9c74ca3db444fb9a5c29eb28217a2cf
Autor:
Katherine Fuh, Kathleen Moore, Thais Baert, Thomas Herzog, David Cibula, Joyce Liu, Laurianne Eberst, Sharon Lewin, Angeles Alvarez Secord, Jalid Sehouli, Tashanna Myers, Aristotelis Bamias, BJ Rimel, Nicoletta Colombo, Amy Franke, Dipti Shoop, Ugo De Giorgi, Joanna Pikiel, Rebecca Bowen, Antonio Gonzalez-Martin
Publikováno v:
E-Posters (Trials In Progress).
Autor:
Elizabeth Lee, Nabihah Tayob, BJ Rimel, Andrea Wahner Hendrickson, Andrew Nixon, Ursula Matulonis, Joyce Liu
Publikováno v:
E-Posters (Trials In Progress).
Autor:
Andrew J. Li, Paul-Joseph Aspuria, Bj Rimel, Matthew T. Siedhoff, Kelly N. Wright, Simon A. Gayther, Lourdes Hernandez, Beth Y. Karlan, Fabiola Medeiros, Robbin Nameki, Marcela A. Haro, Huy Q. Dinh, Kate Lawrenson, Xianzhi Lin, Claire E. Olingy, Heidi Chang, Rosario I. Corona, Forough Abbasi
Publikováno v:
Cell reports, vol 35, iss 2
Cell Rep
Cell Reports, Vol 35, Iss 2, Pp 108978-(2021)
Cell Rep
Cell Reports, Vol 35, Iss 2, Pp 108978-(2021)
Summary The human fallopian tube harbors the cell of origin for the majority of high-grade serous “ovarian” cancers (HGSCs), but its cellular composition, particularly the epithelial component, is poorly characterized. We perform single-cell tran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0a76c947a5bf77fb95d08728a092264
https://escholarship.org/uc/item/7hr243sx
https://escholarship.org/uc/item/7hr243sx
Autor:
Yanfei Xu, Allison Saiz, Bj Rimel, Bradley Corr, Angeles Alvarez Secord, Leslie Horn Clark, Masha Kocherginsky, Tia Schering, Kelly A. Benante, Kiril Kalinichenko, Edward Sauter, Goli Samimi, Eileen Dimond, Seema Ahsan Khan, Emma Longley Barber
Publikováno v:
Journal of Clinical Oncology. 40:TPS5601-TPS5601
TPS5601 Background: Endometrial Intraepithelial Neoplasia (EIN) is a precursor lesion to endometrial carcinoma (EC), the most common gynecologic cancer among women in the US. The current standard of care for women with EIN is hysterectomy. Non-surgic
Autor:
Victoria Cerda, Nooshin Karamzadeh, Marla Scott, Nolan Kinne, Christopher Mayer, Kristin Taylor, Andrew John Li, Kenneth H. Kim, Fabiola Medeiros, Bonnie Balzer, Bj Rimel
Publikováno v:
Journal of Clinical Oncology. 40:e17526-e17526
e17526 Background: Adenocarcinoma and adenosquamous carcinoma of the cervix are subtypes of HPV related cervical cancer. As virally mediated tumors, they have become an obvious choice for immunotherapy treatment approach. Currently, there is little i
Autor:
Matthew T. Siedhoff, Rosario I. Corona, Andrew J. Li, Bj Rimel, Paul-Joseph Aspuria, Simon A. Gayther, Forough Abbasi, Heidi Chang, Fabiola Medeiros, Beth Y. Karlan, Huy Q. Dinh, Kate Lawrenson, Lourdes Hernandez, Robbin Nameki, Kelly N. Wright, Claire E. Olingy, Xianzhi Lin, Marcela A. Haro
SummaryThe human fallopian tube harbors the cell-of-origin for the majority of high-grade serous ‘ovarian’ cancers (HGSCs), but its cellular composition, particularly the epithelial component, is poorly characterized. We performed single-cell tra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a59f9ec5b283d2e6570eb92f34185a24
https://doi.org/10.1101/2020.05.28.119933
https://doi.org/10.1101/2020.05.28.119933
Autor:
Kathleen N. Moore, J. Gillen, Abigail Fong, Christine S. Walsh, Catherine John, Andrew J. Li, Bj Rimel, Farin Amersi, Ilana Cass
Publikováno v:
Gynecologic Oncology. 156:e27-e28
5565 Background: Patients with BRCA mutations are at increased risk of developing both breast (BC) and epithelial ovarian cancer (EOC). Optimal breast cancer surveillance guidelines for BRCA mutation carriers following EOC has not been defined due to
Publikováno v:
Journal of Clinical Oncology. 37:TPS5609-TPS5609
TPS5609 Background: The Cancer Genome Atlas and others identified genomic events suggesting that endometrial cancer (EC) should be susceptible to DNA repair inhibition. Mutations in classical homologous recombination genes occur in 22% of EC, ARID1A